Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CVS Health's (CVS) consumer centric digital strategy is even more relevant amid the pandemic.

CVS Health Prescription Volume Solid, Price Cut Woes Stay

WOONSOCKET, R.I., Nov. 11, 2020 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) today announced that Daniel Finke has been named Executive Vice President, CVS Health and President, Health Care Benefits Segment (HCB) effective February 1, 2021. Finke will succeed Karen S. Lynch, who...

CVS Health Names Daniel Finke President of Health Care Benefits Segment

Walgreens

Shares of Walgreens Boots Alliance Inc. surged 8.1% in midday trading Tuesday, enough to pace the Dow Jones Industrial Average's gainers, amid continued investor optimism over a potential COVID-19 vaccine. The stock, which is on track to close at a four-month high, has now run up 28.3% in eight sessions since it closed at an 8-year low of $33.52 on Oct. 29.

Walgreens, CVS stocks extend big rallies, amid optimism over COVID vaccine administration

CVS Health stock is down 12% since the start of the year and it has gained around 23% from its March lows. CVS Health could offer an upside in the near term, as the company's revenues in the last two quarters have grown by 3%.

CVS Health Stock Remains Attractive At $65

Those quarterly dividend payments aren't going to stay frozen much longer.

3 Reasons CVS Health Is a Top Healthcare Stock to Buy Now

CVS Health CEO Larry Merlo says thousands of drugstores will be ready to vaccinate Americans against Covid-19 once the U. S. government gives the green light.

CVS CEO: Pharmacies Ready To Distribute Covid-19 Vaccines Once Approved

Block

Uber

Alteryx

Alteryx, Uber, Square and CVS are all making notable moves on Friday thanks to earnings, which made them our top stock trades to watch. The post 4 Top Stock Trades for Monday: SQ, UBER, CVS, AYX appeared first on InvestorPlace.

4 Top Stock Trades for Monday: SQ, UBER, CVS, AYX

The healthcare giant reported better-than-expected third-quarter results.

Why CVS Health Stock Jumped Today

What's the prognosis for CVS stock? Here is what the fundamentals and technical analysis say about buying CVS stock now.

CVS Stock: Is It A Buy Right Now? Here's What Earnings, Charts Show As CVS Customers Don Masks

CVS Health Corporation (CVS) CEO Larry Merlo on Q3 2020 Results - Earnings Call Transcript

CVS Health Corp. (NYSE: CVS) published its financial results on Friday that topped analysts' estimates for earnings and revenue in the fiscal third quarter. The company attributed its hawkish performance to robust demand for COVID-19 testing.

CVS Health Corp tops analysts' estimates for earnings and revenue in fiscal Q3

CVS Health has named Karen Lynch as its new CEO, making the company the largest by revenue to be led by a woman. Lynch, who is president of CVS' Aetna division, helped steer the $69 billion merger between healthcare retailer CVS and health insurance giant Aetna in 2018.

CVS Health Now Biggest Company With Female CEO, Amid Strong Q3 Earnings

CVS Health Corp Chief Executive Officer Larry Merlo will retire after a decade-long tenure at the helm of the company during which he led the $69 billion acquisition of one of the oldest U.S. health insurer, Aetna.

CVS Health CEO Larry Merlo to step down next year

Karen Lynch is set to take over as the new CEO of CVS Health (CVS) as current CEO Larry Merlo prepares to retire in May 2021. The post Meet New CVS CEO Karen Lynch: 14 Things to Know appeared first on InvestorPlace.

Meet New CVS CEO Karen Lynch: 14 Things to Know

CVS Health's (CVS) Q3 pharmacy claims processed rise attributable to strong net new business, partially offset by reduced new therapy prescriptions.

CVS Health (CVS) Q3 Earnings Top Estimates, 2020 View Up

CVS will soon be the largest US company run by a woman.  CVS Health announced that Karen Lynch, the president of Aetna and executive vice president of CVS Health, will take over for current CEO Larry Merlo upon his retirement in February 1, 2020. CVS Health bought Aetna, a health insurance company, in 2018 for $70 billion.

CVS will become the biggest Fortune 500 company to be run by a woman as Karen Lynch becomes CEO (CVS)

There were just 32 female CEOs of S&P 500 companies as of September.

CVS Health Names New CEO, Increasing Female Leadership Of S&P 500 Companies

When CVS Health Corp. (NYSE: CVS) reported its third-quarter financial results before the markets opened on Wednesday, the pharmacy chain posted $1.66 in earnings per share (EPS) and $67.1 billion in revenue.

CVS Investors Cheer Earnings and New CEO Appointee

Before the opening bell on Nov. 6, CVS Health Corp. (NYSE:CVS) released third-quarter results that topped Wall Street's expectations.

What's Behind CVS Health Corp's Fabulous Performance?

The shares of CVS Health Corp (NYSE:CVS) are up 1.9% at $61.41 in pre-market trading, after the pharmaceutical company named Executive Vice President Karen Lynch as its next CEO.

CVS Stock Pointed Higher on New CEO Buzz, Earnings Beat

CVS Health has announced that Karen Lynch will be elevated to CEO, making her the 40th female chief executive on the Fortune 500 list.

CVS names female CEO, expanding ranks of women leading Fortune 500 companies

Alphabet

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Some companies are just too big and too resilient to hold back.

3 Top Large-Cap Stocks to Buy in November

CVS Health said longtime Aetna executive Karen Lynch, the drugstore chain's current executive vice president, will take over from Larry Merlo as president and CEO effective Feb. 1, 2021.

CVS Health CEO Larry Merlo To Hand Over Reigns To Longtime Aetna Executive Karen Lynch

CVS Health (CVS) delivered earnings and revenue surprises of 23.88% and 0.78%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates

The health-care company's quarterly revenue rose as it benefited from providing a wide range of health-care services from insurance to Covid-19 tests.

News for CVS Health Stock (CVS)